MedSciNet AB has joined forces in Strategic Alliance with ANTAEA Medical Services of Athens, Greece, to expand its market reach in Southeast Europe, North Africa, Middle East, and the Gulf Area.
While MedSciNet AB will provide ANTAEA with its IT technical expertise in clinical trials and medical software solutions, ANTAEA will support MedSciNet AB with its global market development strategies.
Founded in 1998, the ANTAEA Group of Companies is one of the leading regional CROs providing professional, high quality, and flexible solutions, supporting pharmaceutical and biotechnology companies to maximise their research capabilities via cost-effective outsourcing. ANTAEA is dedicated to provide services presenting scientific quality, management expertise, and leading-edge technology.
Both companies agreed on co-development of models that will maximise the effectiveness and efficacy of clinical trial conduct as well as cost reductions for clients. MedSciNet AB and ANTAEA strongly believe that the interests of both businesses are best served by their joint synergies and collaboration in the global market place.
For more information on the ANTAEA Group of Companies please visit www.antaea.com.
Professor Magnus Westgren, Chairman of the Board and 50% owner of MedSciNet, comments the agreement: “We are looking forward to this joint project with great potential for the future of both companies.”
“As a CRO strongly believing in added value of advanced technologies in early decision-making as well as shortening time-to-market in drug development, we welcome this Strategic Alliance as a major step in service improvement for the clients of both our companies,” says John Roussos, MSc MedPhys, CEO and 50% owner of ANTAEA Medical Services Ltd.